Sanofi-Aventis Czech Republic - Total Asset Growth

Created with Highcharts 6.0.4%2005200620072008200920102011201220132014201520162017-40-20020406080100

Sanofi-Aventis CR`s Total Asset Growth reached 12.1 % in 2017. This is 38.9 % more than in the previous year.

$1.99

Buy Total Asset Growth data for Sanofi-Aventis Czech Republic.

$19.99

Buy all data for Sanofi-Aventis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
CompanyUnit
Amgen Czech Republic %
Bayer Czech Republic %
GlaxoSmithKline Czech Republic %
Merck Czech Republic %
Novartis Czech Republic %
Pfizer Czech Republic %
Roche Czech Republic %
Sanofi-Aventis Czech Republic %
Servier Czech Republic %
Walmark %
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
... ... ... ... ...           36.5 14.1 -15.6 22.4 3.28    
... ... ...               -41.7 -26.0 22.0 -2.28 21.7    
... ... ...               15.9 -23.6 -1.81 -15.0 4.34    
... ...                 25.8 12.5 8.86 -12.5 11.3    
                    12.2 8.05 -0.432 9.23 16.1    
... ...                 -3.91 -12.3 11.1 3.91 -33.7    
... ... ...               -9.52 4.74 -4.23 3.23 9.98   ...
... ... ... ...             1.84 4.11 -18.3 -12.8 12.2    
... ... ... ... ... ... ... ... ... ... ... ... 15.0 129 13.3    
... ... ...               -2.00 -7.16 23.1 6.71 -23.3